Worth Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Worth Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50	Closed	-$165	–	456
2023 Q2	$165	Hold	50	–	–	﹤0.01%	443
2023 Q1	$455	Hold	50	–	–	﹤0.01%	456
2022 Q4	$587	Hold	50	–	–	﹤0.01%	441
2022 Q3	$1K	Hold	50	–	–	﹤0.01%	443
2022 Q2	$1K	Hold	50	–	–	﹤0.01%	518
2022 Q1	$2K	Buy	+50	New	+$2.47K	﹤0.01%	491

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Worth Asset Management's VBIV Position: Q3 2023 in Review

Worth Asset Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 50 shares — an estimated $165 sold.

Worth Asset Management first reported a position in VBIV in Q1 2022 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

Worth Asset Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
Worth Asset Management sold 50 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $165.
Worth Asset Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2022 and held it in 6 quarters.
Worth Asset Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2K in Q1 2022.
37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.